97557-30-7 Usage
Uses
1. Used in Pharmaceutical Applications:
(Asparaginyl-alanyl-asparaginyl-proline)3 is used as a potential therapeutic agent for various medical conditions due to its unique amino acid sequence and potential bioactive properties. Further research is required to explore its specific applications and efficacy in treating different diseases.
2. Used in Nutritional Supplements:
As a tripeptide, (Asparaginyl-alanyl-asparaginyl-proline)3 may be used as an ingredient in nutritional supplements, particularly those aimed at enhancing protein synthesis and overall health. Its role in these supplements would be to provide the body with essential amino acids and support various biological processes.
3. Used in Cosmetics:
In the cosmetics industry, (Asparaginyl-alanyl-asparaginyl-proline)3 could be utilized for its potential skin-beneficial properties, such as promoting collagen production or improving skin elasticity. Its incorporation into skincare products may contribute to anti-aging effects and overall skin health.
4. Used in Research and Development:
(Asparaginyl-alanyl-asparaginyl-proline)3 serves as a valuable compound for researchers in the fields of biochemistry, molecular biology, and pharmacology. It can be used as a model system to study the structure-function relationships of peptides and their interactions with other biomolecules, leading to a better understanding of their potential applications in medicine and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 97557-30-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,5,5 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97557-30:
(7*9)+(6*7)+(5*5)+(4*5)+(3*7)+(2*3)+(1*0)=177
177 % 10 = 7
So 97557-30-7 is a valid CAS Registry Number.
InChI:InChI=1/C48H74N18O19/c1-19(56-40(76)22(49)13-31(50)67)37(73)61-25(16-34(53)70)45(81)64-10-4-7-28(64)43(79)59-23(14-32(51)68)41(77)57-20(2)38(74)62-26(17-35(54)71)46(82)65-11-5-8-29(65)44(80)60-24(15-33(52)69)42(78)58-21(3)39(75)63-27(18-36(55)72)47(83)66-12-6-9-30(66)48(84)85/h19-30H,4-18,49H2,1-3H3,(H2,50,67)(H2,51,68)(H2,52,69)(H2,53,70)(H2,54,71)(H2,55,72)(H,56,76)(H,57,77)(H,58,78)(H,59,79)(H,60,80)(H,61,73)(H,62,74)(H,63,75)(H,84,85)/t19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-/m0/s1
97557-30-7Relevant articles and documents
Solid-phase peptide synthesis in highly loaded conditions
Nakaie, Clovis R.,Oliveira, Eliandre,Vicente, Eduardo F.,Jubilut, Guita N.,Souza, Sinval E.G.,Marchetto, Reinaldo,Cilli, Eduardo M.
, p. 101 - 109 (2011)
The use of very highly substituted resins has been avoided for peptide synthesis due to the aggravation of chain-chain interactions within beads. To better evaluate this problem, a combined solvation-peptide synthesis approach was herein developed taking as models, several peptide-resins and with peptide contents values increasing up to near 85%. Influence of peptide sequence and loading to solvation characteristics of these compounds was observed. Moreover, chain-chain distance and chain concentration within the bead were also calculated in different loaded conditions. Of note, a severe shrinking of beads occurred during the α-amine deprotonation step only when in heavily loaded resins, thus suggesting the need for the modification of the solvent system at this step. Finally, the yields of different syntheses in low and heavily loaded conditions were comparable, thus indicating the feasibility of applying this latter "prohibitive" chemical synthesis protocol. We thought these results might be basically credited to the possibility, without the need of increasing molar excess of reactants, of carrying out the coupling reaction in higher concentration of reactants - near three to seven folds - favored by the use of smaller amount of resin. Additionally, the alteration in the solvent system at the α-amine deprotonation step might be also improving the peptide synthesis when in heavily loaded experimental protocol.
